Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics Inc | RCV000201166 | SCV000255776 | pathogenic | Charcot-Marie-Tooth disease, type 4J | 2014-01-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000623247 | SCV000740820 | pathogenic | Inborn genetic diseases | 2015-01-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001090680 | SCV001246357 | pathogenic | not provided | 2019-07-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001235453 | SCV001408139 | pathogenic | Charcot-Marie-Tooth disease type 4 | 2019-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg381*) in the FIG4 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs377357931, ExAC 0.04%). This variant has been observed in individual(s) with Charcot-Marie-Tooth disease (PMID: 21705420). ClinVar contains an entry for this variant (Variation ID: 217228). Loss-of-function variants in FIG4 are known to be pathogenic (PMID: 23623387). For these reasons, this variant has been classified as Pathogenic. |